-
Is Allergan Going After Valeant's Eye Surgery Assets?
Friday, November 18, 2016 - 12:47pm | 222It is no secret that Valeant Pharmaceuticals Intl Inc (NYSE: VRX) needs to divest some of its assets to give the company sufficient liquidity to reduce its debt load before it becomes potentially unmanageable. The Wall Street Journal reported in early November that the pharmaceutical company has...